Substituted 2-carbonylamino-6-piperidinaminopyridines and substituted 1-carbonylamino-3-piperidinaminobenzenes as 5-HT1F agonists
A Standard patent application filed on 03 September 2004 credited to Ying, Bai-Ping
;
Mathes, Brian Michael
;
Benesh, Dana Rae
;
Kohlman, Daniel Timothy
;
Zacherl, Deanna Piatt
;
Xu, Yao-Chang
;
Victor, Frantz
;
Hudziak, Kevin John
;
Blanco-Pillado, Maria-Jesus
;
Cohen, Michael Philip
;
Filla, Sandra Ann
Details
Application number :
2004280320
Application type :
Standard
Application status :
SEALED
Under opposition :
No
Proceeding type :
Invention title :
Substituted 2-carbonylamino-6-piperidinaminopyridines and substituted 1-carbonylamino-3-piperidinaminobenzenes as 5-HT1F agonists
Inventor :
Ying, Bai-Ping
;
Mathes, Brian Michael
;
Benesh, Dana Rae
;
Kohlman, Daniel Timothy
;
Zacherl, Deanna Piatt
;
Xu, Yao-Chang
;
Victor, Frantz
;
Hudziak, Kevin John
;
Blanco-Pillado, Maria-Jesus
;
Cohen, Michael Philip
;
Filla, Sandra Ann
Agent name :
Spruson & Ferguson
Address for service :
Level 35 St Martins Tower 31 Market Street Sydney NSW 2000 Australia
Filing date :
03 September 2004
Associated companies :
Applicant name :
Eli Lilly and Company
Applicant address :
Lilly Corporate Center Indianapolis Indiana 46285 United States of America